The discovery and development of new drugs has been revolutionised over the last two decades by advances in synthetic chemistry coupled with the development of molecular and structural biology. The Medicinal Chemistry and Structural Biology division in the School of Pharmacy provides a unique multidisciplinary environment for PhD study, giving graduates from a wide variety of backgrounds in the physical and life sciences the opportunity to contribute to the development of new treatments for many different diseases. Working in this group allows students to work with those with a proven track record in taking new molecules from discovery to clinical trials, and on to the market.
Ongoing research themes within the group include: combinatorial chemistry; cancer chemotherapy; computational chemistry; novel biomolecules from microbial sources; x-ray crystallography; protein structure elucidation and the generation of new compounds targeted towards specific molecular entities or cells. The division is well equipped to undertake cutting-edge medicinal chemistry and structural biology research and houses state-of-the-art equipment within the purpose built Centre for Biomolecular Sciences.